Back to Search
ANNA BERKENBLIT, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1962646307Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
156977(MA)
Research & Publications (14)
Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features.
PMID 18385198·Ann Oncol·2008
2-rct
Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors.
PMID 17255281·Clin Cancer Res·2007
3-trial
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial.
PMID 16023182·Gynecol Oncol·2005
3-trial
A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.
PMID 15581974·Gynecol Oncol·2004
3-trial
Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin.
PMID 12798716·Gynecol Oncol·2003
3-trial
Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer.
PMID 19415181·Invest New Drugs·2010
3-trial
Analysis of PTEN and HIF-1alpha and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-alpha.
PMID 19526589·Cancer·2009
3-trial
Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.
PMID 19581539·J Clin Oncol·2009
3-trial
Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies.
PMID 19229667·Med Oncol·2009
3-trial
Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study.
PMID 17882656·Cancer Invest·2007
3-trial
Ovarian carcinoma with thyroid metastases causing clinical hypothyroidism: a case report.
PMID 16564565·Gynecol Oncol·2006
5-case
Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer.
PMID 16062072·Am J Clin Oncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 35 CAMBRIDGE PARK DR.
CAMBRIDGE, MA 02140 - Phone
- (617) 665-7796
Quick Facts
- NPI
- 1962646307
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile